The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Golgi fragmentation - One of the earliest organelle phenotypes in Alzheimer's disease neurons
Published version of a preprint
Abstract
Alzheimer’s disease (AD) is the most common cause of dementia, with no current cure. Consequently, alternative approaches focusing on early pathological events in specific neuronal populations, besides targeting the well-studied amyloid beta (Aβ) accumulations and Tau tangles, are needed. In this study, we have investigated disease phenotypes specific to glutamatergic forebrain neurons and mapped the timeline of their occurrence, by implementing familial and sporadic human induced pluripotent stem cell models as well as the 5xFAD mouse model. We recapitulated characteristic late AD phenotypes, such as increased Aβ secretion and Tau hyperphosphorylation, as well as previously well documented mitochondrial and synaptic deficits. Intriguingly, we identified Golgi fragmentation as one of the earliest AD phenotypes, indicating potential impairments in protein processing and post-translational modifications. Computational analysis of RNA sequencing data revealed differentially expressed genes involved in glycosylation and glycan patterns, whilst total glycan profiling revealed minor glycosylation differences. This indicates general robustness of glycosylation besides the observed fragmented morphology. Importantly, we identified that genetic variants in Sortilin-related receptor 1 ( SORL1 ) associated with AD could aggravate the Golgi fragmentation and subsequent glycosylation changes. In summary, we identified Golgi fragmentation as one of the earliest disease phenotypes in AD neurons in various in vivo and in vitro complementary disease models, which can be exacerbated via additional risk variants in SORL1 .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Human iPSC-derived neurons carrying the familial AD PSEN1 (γ-secretase) mutations or a knock-in of APPswe displayed increased Aβ and Tau production [217].”
From Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations (2024) · cites this paper as [217]
In the citing paper
“Golgi abnormalities, especially Golgi fragmentation, is one of the earliest disease phenotypes displayed by human iPSC-derived neurons carrying familial AD PSEN1 mutations or a knock-in of APPswe [217].”
From Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations (2024) · cites this paper as [217]
In the citing paper
“Golgi fragmentation is one of the earliest disease phenotypes observed in Alzheimer's patient iPSC-derived neurons [217].”
From Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations (2024) · cites this paper as [217]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease
Rogaeva, E., Meng, Y., Lee, J. H., Gu, Y., Kawarai, T., Zou, F., Katayama, T., Baldwin, C. T., Cheng, R., Hasegawa, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1943 · Cited by 1,167
Tau pathology in Alzheimer disease and other tauopathies
Iqbal, K., del C. Alonso, A., Chen, S., Chohan, M. O., El-Akkad, E., Gong, C.-X., Khatoon, S., Li, B., Liu, F., Rahman, A., et al. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.09.008 · Cited by 1,037 · cited 1×
“Together with intracellular neurofibrillary tangles (NFTs), caused by Tau hyperphosphorylation, these are considered classical pathological hallmarks of AD (Iqbal et al., 2005; Metaxas and Kempf, 2016; Selkoe and Hardy, 2016) and are characteristic in late stages of AD.”
BackgroundReview Article: Genetics of Alzheimer Disease
Bekris, L. M., Yu, C.-E., Bird, T. D., & Tsuang, D. W. (2010) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988710383571 · Cited by 1,029 · cited 1×
“Familial AD (fAD) presents as early-onset AD and is caused by mutations in Presenilin 1, Presenilin 2 (PSEN1, PSEN2) or Amyloid Precursor Protein (APP) (Bekris et al., 2010).”
BackgroundAn atlas of human long non-coding RNAs with accurate 5′ ends
Hon, C.-C., Ramilowski, J. A., Harshbarger, J., Bertin, N., Rackham, O. J. L., Gough, J., Denisenko, E., Schmeier, S., Poulsen, T. M., Severin, J., et al. (2017) · Nature · doi:10.1038/nature21374 · Cited by 1,007
Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology
Moreira, P. I., Carvalho, C., Zhu, X., Smith, M. A., & Perry, G. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.10.006 · Cited by 734
History and progress of hypotheses and clinical trials for Alzheimer’s disease
Liu, P.-P., Xie, Y., Meng, X.-Y., & Kang, J.-S. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0063-8 · Cited by 723 · cited 1×
“Mitochondria, metabolic deficits and synaptic dysfunction have been widely studied in relation to AD, and it is evident that all of these are implicated in disease progression (Balaban et al., 2005; Moreira et al., 2010; Marsh and Alifragis, 2018; Liu et al., 2019).”
BackgroundJohnson, E. C. B., Carter, E. K., Dammer, E. B., Duong, D. M., Gerasimov, E. S., Liu, Y., Liu, J., Betarbet, R., Ping, L., Yin, L., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-021-00999-y · Cited by 561
Neuronal Cell Death in Alzheimers Disease and a Neuroprotective Factor, Humanin
Niikura, T., Tajima, H., & Kita, Y. (2006) · Current Neuropharmacology · doi:10.2174/157015906776359577 · Cited by 184
Research works printed but not linked: 54
- Adams, 2020, Skyline for small molecules: a unifying software package for quantitative metabolomics., J. Proteome Res., 19, 1447, 10.1021/ACS.JPROTEOME.9B00640 · DOI · Paper page
- Afzal, 2021, Effect of crista morphology on mitochondrial ATP output: a computational study., Curr. Res. Physiol., 4, 163, 10.1016/J.CRPHYS.2021.03.005 · DOI
- 2022, More than normal aging: understanding mild cognitive impairment., Alzheimers Dement., 18, 545
- Andersen, 2005, Neuronal sorting protein-related receptor SorLA/LR11 regulates processing of the amyloid precursor protein., Proc. Natl. Acad. Sci. U.S.A., 102, 10.1073/PNAS.0503689102 · DOI · Paper page
- Antón-Fernández, 2017, Morphometric alterations of golgi apparatus in Alzheimer’s disease are related to tau hyperphosphorylation., Neurobiol. Dis., 97, 10.1016/J.NBD.2016.10.005 · DOI
- Balaban, 2005, Mitochondria, oxidants, and aging., Cell, 120, 483, 10.1016/J.CELL.2005.02.001 · DOI · Paper page
- Baloyannis, 2014, Golgi apparatus and protein trafficking in Alzheimer’s disease., J. Alzheimers Dis., 42, S153, 10.3233/JAD-132660 · DOI
- Berchtold, 2014, Brain gene expression patterns differentiate mild cognitive impairment from normal aged and Alzheimer’s disease., Neurobiol. Aging, 35, 1961, 10.1016/J.NEUROBIOLAGING.2014.03.031 · DOI · Paper page
- Cai, 2003, Presenilin-1 regulates intracellular trafficking and cell surface delivery of β-amyloid precursor protein., J. Biol. Chem., 278, 3446, 10.1074/jbc.M209065200 · DOI · Paper page
- Corsi, CRISPRroots: on- and off-target assessment of RNA-Seq data in CRISPR–Cas9 edited cells., Nucleic Acids Res., 50, 10.1093/NAR/GKAB1131 · DOI
- Corsi, The transcriptomic landscape of neurons carrying PSEN1 mutations reveals changes in extracellular matrix components and non-coding gene expression., Neurobiol. Dis., 178, 10.1016/J.NBD.2022.105980 · DOI
- Damerell, 2012, The glycanbuilder and glycoworkbench glycoinformatics tools: updates and new developments., Biol. Chem., 393, 1357, 10.1515/HSZ-2012-0135 · DOI · Paper page
- de Haan, 2022, In-depth profiling of O-glycan isomers in human cells using C18 nanoliquid chromatography–mass spectrometry and glycogenomics., Analyt. Chem., 94, 4343, 10.1021/ACS.ANALCHEM.1C05068 · DOI
- Dobin, 2013, STAR: ultrafast universal RNA-Seq aligner., Bioinformatics, 29, 15, 10.1093/BIOINFORMATICS/BTS635 · DOI · Paper page
- Fjorback, 2012, Retromer binds the FANSHY sorting motif in SorLA to regulate amyloid precursor protein sorting and processing., J. Neurosci., 32, 1467, 10.1523/JNEUROSCI.2272-11.2012 · DOI · Paper page
- Frankish, 2019, GENCODE reference annotation for the human and mouse genomes., Nucleic Acids Res., 47, D766, 10.1093/NAR/GKY955 · DOI · Paper page
- Frederiksen, 2019, Generation of two IPSC lines with either a heterozygous V717I or a heterozygous KM670/671NL mutation in the APP gene., Stem Cell Res., 34, 10.1016/J.SCR.2018.101368 · DOI
- García-Escudero, 2013, Deconstructing mitochondrial dysfunction in Alzheimer disease., Oxid. Med. Cell. Longev., 2013, 10.1155/2013/162152 · DOI
- Ikeuchi, 2010, Increased levels of soluble LR11 in cerebrospinal fluid of patients with Alzheimer disease., Dement. Geriatr. Cogn. Disord., 30, 28, 10.1159/000315539 · DOI
- Joshi, 2015, Golgi fragmentation in Alzheimer’s disease., Front. Neurosci., 9, 10.3389/FNINS.2015.00340 · DOI
- Joshi, 2014, Aβ-induced golgi fragmentation in Alzheimer’s disease enhances Aβ production., Proc. Natl. Acad. Sci. U.S.A., 111, E1230, 10.1073/pnas.1320192111 · DOI · Paper page
- Kedia, 2020, Real-time nanoscale organization of amyloid precursor protein., Nanoscale, 12, 8200, 10.1039/D0NR00052C · DOI
- Kedia, 2021, Alteration in synaptic nanoscale organization dictates amyloidogenic processing in Alzheimer’s disease., IScience, 24, 10.1016/j.isci.2020.101924 · DOI
- Kizuka, 2017, N-Glycan and Alzheimer’s disease., Biochim. Biophys. Acta Gen. Subj., 1861, 2447, 10.1016/j.bbagen.2017.04.012 · DOI
- Kizuka, 2016, Bisecting GlcNAc modification stabilizes BACE1 protein under oxidative stress conditions., Biochem. J., 473, 21, 10.1042/BJ20150607 · DOI · Paper page
- Kumar-Singh, 2006, Mean age-of-onset of familial alzheimer disease caused by presenilin mutations correlates with both increased abeta 42 and decreased abeta 40., Hum. Mutat., 27, 686, 10.1002/humu · doi:10.1002/humu
- Lageveen-Kammeijer, 2019, Highly sensitive CE-ESI-MS analysis of N-glycans from complex biological samples., Nat. Commun., 10, 10.1038/S41467-019-09910-7 · DOI
- Li, 2019, Golgi structure and function in health, stress, and diseases., Results Probl. Cell Diff., 67, 441, 10.1007/978-3-030-23173-6_19/TABLES/2 · doi:10.1007/978-3-030-23173-6_19/tables/2
- Li, 2016, Generation of induced pluripotent stem cells (IPSCs) from an Alzheimer’s disease patient carrying an A79V mutation in PSEN1., Stem Cell Res., 16, 229, 10.1016/j.scr.2016.01.002 · DOI
- Liao, 2014, FeatureCounts: an efficient general purpose program for assigning sequence reads to genomic features., Bioinformatics, 30, 923, 10.1093/BIOINFORMATICS/BTT656 · DOI · Paper page
- Louwersheimer, 2017, Rare genetic variant in SORL1 may increase penetrance of Alzheimer’s disease in a family with several generations of APOE-ε4 homozygosity., J. Alzheimers Dis., 56, 63, 10.3233/JAD-160091 · DOI
- Marsh, 2018, Synaptic dysfunction in Alzheimer’s disease: the effects of amyloid beta on synaptic vesicle dynamics as a novel target for therapeutic intervention., Neural Regener. Res., 13, 616, 10.4103/1673-5374.230276 · DOI
- Martin, 2011, Cutadapt removes adapter sequences from high-throughput sequencing reads., EMBnet J., 17, 10, 10.14806/EJ.17.1.200 · DOI · Paper page
- Martínez-Menárguez, 2019, Golgi fragmentation in neurodegenerative diseases: is there a common cause?, Cells, 8, 10.3390/CELLS8070748 · DOI
- Metaxas, 2016, Neurofibrillary tangles in Alzheimer’s disease: elucidation of the molecular mechanism by immunohistochemistry and tau protein phospho-proteomics., Neural Regener. Res., 11, 1579, 10.4103/1673-5374.193234 · DOI · Paper page
- Peng, 2021, Identification of SCARA3 with potential roles in metabolic disorders., Aging, 13, 10.18632/AGING.202228 · DOI
- Pires, 2016, Generation of a gene-corrected isogenic control cell line from an Alzheimer’s disease patient IPSC line carrying a A79V mutation in PSEN1., Stem Cell Res., 17, 285, 10.1016/j.scr.2016.08.002 · doi:10.1016/j.scr.2016.08.002
- Pool, 2008, NeuriteTracer: a novel ImageJ plugin for automated quantification of neurite outgrowth., J. Neurosci. Methods, 168, 134, 10.1016/J.JNEUMETH.2007.08.029 · DOI · Paper page
- Poon, 2016, Generation of a gene-corrected isogenic control HiPSC line derived from a familial Alzheimer’s disease patient carrying a L150P mutation in presenilin 1., Stem Cell Res., 17, 466, 10.1016/j.scr.2016.09.018 · doi:10.1016/j.scr.2016.09.018
- Quast, 2013, The SILVA ribosomal RNA gene database project: improved data processing and web-based tools., Nucleic Acids Res., 41, 10.1093/NAR/GKS1219 · DOI · Paper page
- Rasmussen, 2014, Transient P53 suppression increases reprogramming of human fibroblasts without affecting apoptosis and DNA damage., Stem Cell Rep., 3, 404, 10.1016/J.STEMCR.2014.07.006/ATTACHMENT/55CA1981-94D7-441F-B860-5D6D63F62061/MMC1.PDF · doi:10.1016/j.stemcr.2014.07.006/attachment/55ca1981-94d7-441f-b860-5d6d63f62061/mmc1.pdf
- Reynolds, 1963, The use of lead citrate at a high pH as an electron opaque stain in electron microscopy, J. Cell Biol, 17, 208, 10.1083/jcb.17.1.208 · DOI · Paper page
- Schlattner, 2006, Mitochondrial creatine kinase in human health and disease., Biochim. Biophys. Acta, 1762, 164, 10.1016/J.BBADIS.2005.09.004 · DOI · Paper page
- Selkoe, 2016, The amyloid hypothesis of Alzheimer’s disease at 25 years., EMBO Mol. Med., 8, 595, 10.15252/EMMM.201606210 · DOI · Paper page
- Selman, 2011, Cotton HILIC SPE microtips for microscale purification and enrichment of glycans and glycopeptides., Anal. Chem., 83, 2492, 10.1021/AC1027116 · DOI · Paper page
- Shi, 2012, Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks., Nat. Protoc., 7, 1836, 10.1038/nprot.2012.116 · DOI · Paper page
- Sun, 2017, Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of Aβ42 and Aβ40 peptides by γ-secretase., Proc. Natl. Acad. Sci. U.S.A., 114, E476, 10.1073/pnas.1618657114 · DOI · Paper page
- Tan, 2019, The trans-golgi network is a major site for α-secretase processing of amyloid precursor protein in primary neurons., J. Biol. Chem., 294, 10.1074/JBC.RA118.005222 · DOI · Paper page
- Tubsuwan, 2016, Generation of induced pluripotent stem cells (IPSCs) from an Alzheimer’s disease patient carrying a L150P mutation in PSEN-1., Stem Cell Res., 16, 110, 10.1016/j.scr.2015.12.015 · DOI
- Velasco, 1993, Cell type-dependent variations in the subcellular distribution of alpha- mannosidase I and II., J. Cell Biol., 122, 39, 10.1083/JCB.122.1.39 · DOI · Paper page
- Wang, 2012, RSeQC: quality control of RNA-Seq experiments., Bioinformatics, 28, 2184, 10.1093/BIOINFORMATICS/BTS35 · doi:10.1093/bioinformatics/bts35
- Ye, 2005, Apolipoprotein (Apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: ApoE structure as a potential therapeutic target., Proc. Natl. Acad. Sci. U.S.A., 102, 18700, 10.1073/PNAS.0508693102 · DOI · Paper page
- Yu, 2012, Synapses and dendritic spines as pathogenic targets in Alzheimer’s disease., Neural Plast., 2012, 10.1155/2012/247150 · DOI
- Zollo, 2017, Sortilin-related receptor expression in human neural stem cells derived from Alzheimer’s disease patients carrying the APOE epsilon 4 allele., Neural Plast., 2017, 10.1155/2017/1892612 · DOI
Cited by
Wang, J., Fourriere, L., & Gleeson, P. A. (2024) · Biochemical Journal · doi:10.1042/bcj20240056 · Cited by 27
Evolution of the ribbon-like organization of the Golgi apparatus in animal cells
(2024) · doi:10.1016/j.celrep.2024.113791 · Cited by 18
Evolution of the ribbon-like organization of the Golgi apparatus in animal cells
Benvenuto, G., Leone, S., Astoricchio, E., Bormke, S., Jasek, S., D’Aniello, E., Kittelmann, M., McDonald, K., Hartenstein, V., Baena, V., et al. (2023) · doi:10.1101/2023.02.16.528797 · Cited by 1
Metadata
- Authors
- Haukedal, H., Corsi, G. I., Gadekar, V. P., Doncheva, N. T., Kedia, S., de Haan, N., Chandrasekaran, A., Jensen, P., Schiønning, P., Vallin, S., Marlet, F. R., Poon, A., Pires, C., Agha, F. K., Wandall, H. H., Cirera, S., Simonsen, A. H., Nielsen, T. T., Nielsen, J. E., Hyttel, P., Muddashetty, R., Aldana, B. I., Gorodkin, J., Nair, D., Meyer, M., Larsen, M. R., & Freude, K.
- Venue
- Frontiers in Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2023-02-16
- Volume
- 17
- ISSN
- 1662-453X
- Cited by
- 37
- References
- 22
- Funders
- Innovationsfonden (4108-00008B, 4096-00001B)
- Novo Nordisk Fonden (NNF1818OC0052369, NNF21OC0071571, NNF14CC0001)
- Lundbeckfonden (R313-2019-869)
- European Research Council (GlycoSkin H2020-ERC; 772735)
- European Commission (Remodel)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Golgi fragmentation - One of the earliest organelle phenotypes in Alzheimer's disease neurons. https://app.cochat.ai/papers/10.3389/fnins.2023.1120086
- The paper
- Haukedal, H., Corsi, G. I., Gadekar, V. P., Doncheva, N. T., Kedia, S., de Haan, N., Chandrasekaran, A., Jensen, P., Schiønning, P., Vallin, S., Marlet, F. R., Poon, A., Pires, C., Agha, F. K., Wandall, H. H., Cirera, S., Simonsen, A. H., Nielsen, T. T., Nielsen, J. E., . . . Freude, K. (2023). Golgi fragmentation - One of the earliest organelle phenotypes in Alzheimer's disease neurons. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2023.1120086
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.